Xavier M Teitsma

516 citations

16 papers · 181 indexed · h-index 7

Co-authors: J. W. J. Bijlsma Johannes W. G. Jacobs Floris P. J. G. Lafeber Michelle E A Borm Jacob M. van Laar Attila Pethö‐Schramm Paco M J Welsing Amy C. Harms
Topics: Rheumatoid Arthritis Research and Therapies (13 papers)Chronic Lymphocytic Leukemia Research (7 papers)Systemic Lupus Erythematosus Research (6 papers)
Cited by: Rheumatology Hematology Genetics
Journals: PLoS ONE Annals of the Rheumatic Diseases Lara D. Veeken
Partner nations: Netherlands Switzerland Germany

In The Last Decade

Xavier M Teitsma

15 papers receiving 179 citations

Peers

Countries citing papers authored by Xavier M Teitsma

Since Specialization

Citations

This map shows the geographic impact of Xavier M Teitsma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier M Teitsma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier M Teitsma more than expected).

Fields of papers citing papers by Xavier M Teitsma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier M Teitsma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier M Teitsma. The network helps show where Xavier M Teitsma may publish in the future.

Co-authorship network of co-authors of Xavier M Teitsma

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier M Teitsma. A scholar is included among the top collaborators of Xavier M Teitsma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier M Teitsma. Xavier M Teitsma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Epidemiology, clinical characteristics, flares and mortality of generalized pustular psoriasis: a nationwide register study in Finland 2025 ·Skin Health and Disease ·(unknown),Xavier M Teitsma,Juha Mehtälä,(unknown),(unknown),(unknown),(unknown),Rafael Pasternack,(unknown),Laura Huilaja	0
2	Classification, Prediction, and Concordance of Cognitive and Functional Progression in Patients with Mild Cognitive Impairment in the United States: A Latent Class Analysis 2021 ·Journal of Alzheimer s Disease ·(unknown),Keith A. Betts,(unknown),Raluca Ionescu‐Ittu,Lesley M. Butler,Xavier M Teitsma,Paul Delmar,(unknown),(unknown),(unknown),Urvi Desai	6
3	Effect on efficacy and safety trial outcomes of also enrolling patients on ongoing glucocorticoid therapy in rheumatoid arthritis clinical trials of tocilizumab or adalimumab or methotrexate monotherapy 2020 ·Annals of the Rheumatic Diseases ·(unknown),Johannes W. G. Jacobs,Maria J. H. de Hair,Paco M J Welsing,Michael Edwardes,Xavier M Teitsma,Jenny Devenport,Jacob M. van Laar,(unknown),J. W. J. Bijlsma,(unknown)	6
4	Comprehensive exploratory autoantibody profiling in patients with early rheumatoid arthritis treated with methotrexate or tocilizumab 2020 ·PLoS ONE ·Xavier M Teitsma,Jenny Devenport,Johannes W. G. Jacobs,Attila Pethö‐Schramm,Michelle E A Borm,Petra Budde,J. W. J. Bijlsma,Floris P. J. G. Lafeber	3
5	Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis: an indirect comparison of effectiveness and safety of the U-Act-Early and CAMERA-II treat-to-target trials 2019 ·Annals of the Rheumatic Diseases ·(unknown),(unknown),Janneke Tekstra,J. W. J. Bijlsma,Jacob M. van Laar,(unknown),Michelle E A Borm,(unknown),Suzanne P. Linn-Rasker,Xavier M Teitsma,Floris P. J. G. Lafeber,Johannes W. G. Jacobs,Paco M J Welsing	14
6	Explorative analyses of protein biomarkers in patients with early rheumatoid arthritis achieving sustained drug-free remission after treatment with tocilizumab- or methotrexate-based strategies: from transcriptomics to proteomics. 2019 ·PubMed ·Xavier M Teitsma,Johannes W G Jacobs,(unknown),Attila Pethö‐Schramm,Michelle E A Borm,Jacob M. van Laar,J. W. J. Bijlsma,Floris P. J. G. Lafeber	5
7	Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology 2018 ·Arthritis Research & Therapy ·Xavier M Teitsma,Wei Yang,Johannes W. G. Jacobs,Attila Pethö‐Schramm,Michelle E A Borm,Amy C. Harms,Thomas Hankemeier,Jacob M. van Laar,J. W. J. Bijlsma,Floris P. J. G. Lafeber	29
8	Inadequate response to treat-to-target methotrexate therapy in patients with new-onset rheumatoid arthritis: development and validation of clinical predictors 2018 ·Annals of the Rheumatic Diseases ·Xavier M Teitsma,Johannes W. G. Jacobs,Paco M J Welsing,Pascal H P de Jong,Johanna M. W. Hazes,A. Weel,Attila Pethö‐Schramm,Michelle E A Borm,Jacob M. van Laar,Floris P. J. G. Lafeber,J. W. J. Bijlsma	32
9	FRI0026 U-act-early trial 3 years follow-up. the longer effectiveness of treat-to-target strategies in early ra with tocilizumab, methotrexate, or their combination 2018 ·Annals of the Rheumatic Diseases ·(unknown),(unknown),(unknown),Attila Pethö‐Schramm,Michelle E A Borm,Xavier M Teitsma,JM van Laar,F.P. Lafeber,J. W. J. Bijlsma,Johannes W. G. Jacobs	2
10	SAT0169 No evidence that concomitant glucocorticoid therapy affects efficacy and safety of tocilizumab monotherapy in rheumatoid arthritis clinical trials 2018 ·Annals of the Rheumatic Diseases ·M. Safy,J. W. G. Jacobs,M Edwardes,Jinglan Pei,(unknown),Xavier M Teitsma,Paco M J Welsing,Michelle E A Borm,(unknown),JM van Laar,Attila Pethö‐Schramm,J. W. J. Bijlsma	6
11	FRI0040 Development and validation of clinical predictors for inadequate response to treat-to-target methotrexate therapy in newly diagnosed ra patients 2018 ·Annals of the Rheumatic Diseases ·Xavier M Teitsma,J. W. G. Jacobs,(unknown),(unknown),J. M. W. Hazes,A. Weel,Attila Pethö‐Schramm,Michelle E A Borm,J.M. van Laar,F.P. Lafeber,J. W. J. Bijlsma	1
12	SAT0046 Transcript-protein associations in early ra patients achieving sustained drug-free remission after treatment with tocilizumab 2018 ·Annals of the Rheumatic Diseases ·Xavier M Teitsma,J. W. G. Jacobs,(unknown),Attila Pethö‐Schramm,Michelle E A Borm,Jacob M. van Laar,J. W. J. Bijlsma,F.P.J.G. Lafeber	1
13	Patient-reported outcomes in newly diagnosed early rheumatoid arthritis patients treated to target with a tocilizumab- or methotrexate-based strategy 2017 ·Lara D. Veeken ·Xavier M Teitsma,Johannes W. G. Jacobs,Paco M J Welsing,Attila Pethö‐Schramm,Michelle E A Borm,(unknown),(unknown),Jacob M. van Laar,Floris P. J. G. Lafeber,J. W. J. Bijlsma	6
14	Identification of differential co-expressed gene networks in early rheumatoid arthritis achieving sustained drug-free remission after treatment with a tocilizumab-based or methotrexate-based strategy 2017 ·Arthritis Research & Therapy ·Xavier M Teitsma,Johannes W. G. Jacobs,Michal Mokrý,Michelle E A Borm,Attila Pethö‐Schramm,Jacob M. van Laar,J. W. J. Bijlsma,Floris P. J. G. Lafeber	14
15	Radiographic joint damage in early rheumatoid arthritis patients: comparing tocilizumab- and methotrexate-based treat-to-target strategies 2017 ·Lara D. Veeken ·Xavier M Teitsma,Johannes W. G. Jacobs,Paco M J Welsing,Attila Pethö‐Schramm,Michelle E A Borm,Jacob M. van Laar,Floris P. J. G. Lafeber,J. W. J. Bijlsma	14
16	Tocilizumab as monotherapy or combination therapy for treating active rheumatoid arthritis: a meta-analysis of efficacy and safety reported in randomized controlled trials 2016 ·Arthritis Research & Therapy ·Xavier M Teitsma,(unknown),J. W. J. Bijlsma,Floris P. J. G. Lafeber,Johannes W. G. Jacobs	42

About Xavier M Teitsma

Xavier M Teitsma is a scholar working on Rheumatology, Genetics and Hematology, having authored 16 papers that have together received 181 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (13 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Systemic Lupus Erythematosus Research (6 papers). The work is most often cited by research in Rheumatology (132 citations), Hematology (53 citations) and Genetics (25 citations). Xavier M Teitsma has collaborated with scholars based in Netherlands, Switzerland and Germany. Frequent co-authors include J. W. J. Bijlsma, Johannes W. G. Jacobs, Floris P. J. G. Lafeber, Michelle E A Borm, Jacob M. van Laar, Attila Pethö‐Schramm, Paco M J Welsing, Amy C. Harms, Pascal H P de Jong and Thomas Hankemeier. Their work appears in journals such as PLoS ONE, Annals of the Rheumatic Diseases and Lara D. Veeken.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact